Join Our Community
Thanks to the hard work of advocates in the kidney cancer community, Congress has allocated $50 million in federal funding for research in 2021. Twice a year KidneyCAN organizes calls and visits to congress to speak about the need for kidney cancer research. We need your help to continue the progress in funding kidney cancer research.
FOR PATIENTS
Whether you are a patient, caregiver, family member or friend, there is no greater way to impact our lawmakers than to share how kidney cancer has impacted your life. The passion you have to pursue advanced treatments or cure will translate to action! Patients and their families are at the heart of the grassroots army that has taken earmarked federal dollars for research from $0 to $50 million a year.
You and your loved ones can be a part of this army! There is strength and empowerment in “giving back”.
WHY ADVOCATE?
GET INVOLVED
FOR HEALTHCARE PROFESSIONALS
Our physician engagement is growing!
There is a tremendous benefit in having your voice heard, often with one or more of your patients. This amplifies the importance of these dollars for you and your ability to treat your patients.
Everything will be arranged for you and the training is brief. You will be well prepared to get the conversation started. We’d love to have your voice heard as an advocate for your state.
Physician voices amplify and enhance the patient and caregiver stories, resulting in more dollars for research!
ADVOCATE FOR RESEARCH FUNDING
SPEAK UP FOR FUNDING
KidneyCAN President Bryan Lewis and Dr. Andrew Smith of University of Alabama at Birmingham describe the importance of advocating for kidney cancer research funding and the impact it has on patient treatment.
SPEAK UP FOR FUNDING
KidneyCAN President Bryan Lewis and Dr. Andrew Smith of University of Alabama at Birmingham describe the importance of advocating for kidney cancer research funding and the impact it has on patient treatment.
RESEARCH OPPORTUNITIES
KCRS INFO & PRESENTATIONS
FOR RESEARCHERS
You might be here on the KidneyCAN site learning more about the DoD CDMRP Kidney Cancer Research Awards.
Did you know you can impact the amount of research dollars ultimately allocated? Your firsthand account of the cost and value of cancer research provides a unique and needed perspective when we talk to congressional representatives.
Please take the opportunity and support these advocacy visits and be part of the powerful, united voice we need to make a difference! We need basic science and translational researchers to be part of this grassroots army.
Join Our Grassroots Army
Join Us!
Join this free symposium to understand how your quality of life and symptom management during #kidneycancer treatment can be improved by support from palliative care specialists.
This event is provided by our friends at the Judy Nicholson Kidney Cancer Foundation. Register here: https://jnfkidneycancer.org/supporting-patients-family-the-role-of-palliative-care/
Does #kidneycancer run in my family?
What do my genes tell me about kidney cancer?
On October 1st, Dr. Nathanson will break down risks of kidney cancer that runs in families in language we can all understand. She will present the very latest research in the field of kidney cancer genetics, offering information to share with family members and inform decision-making.
More information and registration at: https://www.med.upenn.edu/kidney2021/
Today’s science may lead to breakthrough treatments for a life-threatening condition that affects millions. To deliver on that promise, we need sustained, robust funding for the National Institutes of Health.
Today, KidneyCAN joins Rally for Medical Research to ask #Congress to fund the NIH.
Here's why:
• Medical research funded through the NIH, the largest source of funding for medical research in the world, has been a driving force behind many decades of advances that have improved the health of people in every corner of America.
• Thanks in large part to NIH-funded research, Americans are living longer, healthier lives and advances that were once unimaginable, such as sequencing the human genome, have been achieved and have opened a world of unprecedented opportunities for science, medicine and health.
• NIH funding contributed to every one of the 210 new drugs approved by the Food and Drug Administration (FDA) between 2010 and 2016, including 84 first-in-class products to treat a wide range of diseases.
• Investment in medical research can limit future costs of care. The vast majority of our health care dollars are spent on treating chronic diseases that could be managed more effectively with better therapies or, in some cases, prevented. We can meet these challenges head-on, but in order to do so, medical research must be a strong national priority.
#RallyMedRes #FundNIH
Did you know? September 21 is #TakeALovedOneToTheDoctor day!
Building a care team and getting support is a key piece of your cancer journey. Check out KidneyCAN's resources for patients and caregivers at https://kidneycan.org/build-a-care-team/
We just published our August newsletter, filled with exciting #kidneycancer research updates, news, and events. Don't miss a very special feature highlighting an inspiring member of our community.
Have a great weekend!
https://conta.cc/3sRMguh
REMINDER: Do you have questions about participating in clinical trials and how to find trials for you? Do you know the risks and benefits? We are hosting a special Facebook Live with a medical oncologist and clinical trial patient to answer all your questions live, including:
• What is a clinical trial?
• Where do I find clinical trials for kidney cancer?
• What are important questions to ask about a trial?
• What is informed consent?
• What are good clinical practices?
• What can patients expect during a trial?
• What are the risks and benefits of participating in a trial?
• What is the difference between participating at an academic institution versus a freestanding clinical research organization (CRO)?
Will you join us? RSVP now so you get a Facebook notification when we go live: https://fb.me/e/1JfopJa6J
🚨🚨 RESEARCH NEWS
Lenvantinib (by Eisai) + Keytruda (by Merck) is now
U.S. Food and Drug Administration approved for #kidneycancer. Wonderful to have this powerful new combo as a treatment option for patients with advanced #RCC!
Dr. Toni Choueiri of Dana-Farber Cancer Institute says, "This is another important combination option for advanced kidney cancer patients. The results in term of responses including complete responders are the highest to date, albeit with a bit different patient populations. The hope is to continue building on doublets, like pembro/Len with other active drugs, that are able to induce more deep and sustainable remissions."
Great news!
More information here: https://cancernetwork.com/view/pembrolizumab-lenvatinib-approved-by-the-fda-for-the-treatment-of-first-line-advanced-rcc
We lose almost 40 people per day to kidney cancer in the United States. The need for research funding is urgent.
For #DistrictDays, the #kidneycancer community is meeting with members of #Congress all over the United States to ask for robust funding of kidney cancer research.
We want Congress to
1. Maintain the $50 million currently allocated for KCRP for
Fiscal Year 2022.
2. Increase the NIH budget by $3.5 billion for Fiscal Year 2022.
3. Support the creation of ARPA-H (the Advanced Research
Projects Agency - Health) at NIH with an additional $3 billion.
4. Continue supporting legislative initiatives that contribute to
robust, sustainable funding for medical research.
5. Continue to incorporate the patient perspective on legislative policy matters.
Thank you to the many delegates from all over the country who are speaking on behalf of patients, caregivers, friends, and family members today. Thank you to doctors and researchers from the medical community who've made time today to lift their voices with ours.
Let's work together to #fundthecure.
#AcceleratingCures
Thank you to Senator Grassley's office for meeting with us today. Here, KidneyCAN President and #kidneycancer survivor Bryan Lewis, along with our friend and patient Shari, and Dr. Zakharia speak up about the need for robust research funding.
76,000+ will be diagnosed in 2021.
14,000 Americans will lose their lives to kidney cancer this year.
It's urgent! Let's #fundthecure.
#acceleratingcures #districtdays
Here we go!
#KidneyCancer advocates across the #USA are speaking with #onevoice today. We're asking #Congress to #fundthecure with robust research funding for the National Institutes of Health, the Congressionally Directed Medical Research Programs - Kidney Cancer Research Program, and ARPA-H, which will devote specific funding to cancer research initiatives.
We lose 40 people per day to kidney cancer. This is urgent. The time is NOW.
KidneyCAN is a registered 501(c)(3) nonprofit and does not receive any funding through the Congressionally Directed Medical Research Programs (CDMRP) or KCRP (Kidney Cancer Research Program). Our work is funded by grassroots donors in the kidney cancer community.
